1 / 63

Canada OTC Market Analysis - Sample Report

Over the next few years, the emerging countries of Latin America and Southeast Asia are expected to have the fastest increase in the worldwide over-the-counter (OTC) pharmaceuticals industry. This is due to the fast-rising population in these areas, as well as the growing middle class and growth in disposable income, which will create a critical mass of people who will be able to acquire OTC medications. <br><br>To buy a report, contact us at info@insights10.com<br>Also, you can visit: https://www.insights10.com/report/canada-over-the-counter-otc-pharmaceuticals-market-analysis/<br>

Insights4
Download Presentation

Canada OTC Market Analysis - Sample Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on Canada OTC Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the Canada OTC Pharmaceutical market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Canada OTC Pharmaceutical market, and offers unmatched value, accuracy, and expert insights

  3. • Market Overview • Growth Drivers & Restraints • Market Segmentation • Major Market Share • Competitive Landscape • Key Company Profiles • Notable Deals • Healthcare Policies & Regulatory Framework • Factors Driving Future Growth • Strategic Recommendations Table of Contents

  4. Table of Contents 1. Canada Over the Counter (OTC) Market Overview……………………………..…………..………………….......................7 1.1 Introduction 1.2 Market size and forecast 1.3 Adoption of OTC drugs continues to rise 1.4 Key Aspects of OTC Market 2. Market Growth Drivers and Restraints …………………………………………………………………….…………………….12 2.1 Market Growth Drivers 2.1.1 Rising demand for treatments of minor ailments 2.1.2 Increasing number of health-conscious customers 2.1.3 Product Innovation 2.1.4 Switching of Rx drugs to OTC 2.2 Market Restraints 2.2.1 Irrational use of medicines due to self diagnosis/misdiagnosis 2.2.2 Drug abuse, possibility of drug addiction 4 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  5. Table of Contents (continued) 3. Over the counter (OTC) Market Segmentation………………..……………………………………..…..……….….……..…..19 3.1 By drug type 3.2 By distribution channel 4. Canada Over the Counter (OTC) Major products Market Share ………………………………………………….….....…..24 4.1 Market Analysis, Insights and Forecast - By Revenue 5. Competitive Landscape……………….…………………………………………………………………………………..….…….26 5.1 Major Players Revenue 6. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….………………...…...…....28 6.1 Johnson and Johnson 6.2 Pfizer Inc 6.3 Novartis 6.4 Bayer AG 6.5 Sanofi 7. Canada OTC market: Key notable deals ………………………………….…………………………………………….……....38 5 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  6. Table of Contents (continued) 8. Healthcare Policies and Regulatory Landscape………………………………….………………………………….……..…..40 8.1 Regulatory Framework of Gram-Negative Infection Therapeutic Market 9. Future Development Growth………………………………………………………………………………………….……..….....42 9.1 Future Opportunities 10. Strategic Recommendations.……………………………………………………………………………………….……..…….44 6 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  7. Canada OTC Pharmaceutical Market Analysis 1. Overview

  8. 1.1 Introduction The Canadian over the counter drugs market is projected to grow at a notable rate. This is primarily attributed to the recent product launches, inclination of consumers from prescription medicine to over the counter products, increasing number of diseases, and rising awareness regarding self-medication ▪ About one in five Canadians experience chronic pain. Chronic pain has a significant impact on an individual’s physical and mental health, often preventing them from undertaking everyday activities, as per the Canadian Pain Society 2019 ▪ As per the Chronic Pain Association of Canada (CPAC) 2019 survey, between 17-31% of people has reported chronic pain. 50% of hospitalized patients also reported acute pain of moderate to severe intensity, which has increased the demand for OTC medications ▪ Sample 8 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  9. 1.2 Market Size & Forecast Overview Canada Over the Counter (OTC) Market Size ($Bn) 2021-2030F Key Analysis XX Over the Counter (OTC) Market size in Canada was valued at more than $XX Bn in 2020 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2021 to 2030 ▪ Millions of Canadians visits pharmacies each year to purchase OTC remedies. These products can help treat a wide range of minor complaints, and no prescription is required to buy them ▪ xx Sample 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 9 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  10. 1.3 Adoption of OTC drugs continues to rise Driving forces for OTC drugs market in Canada Lowers the cost of treatment and eliminates the cost of physician meetings, making it more affordable to all patient classes Affordability Smartphone users are expected to rise to XXM in 2024 from which many opportunities are created through apps that help users better with understanding and treatment Telemedicine High penetration of smartphones and access to high-speed internet connectivity will paved the way for telemedicine and online drugs sales, resulting in the growth of OTC healthcare market Sample With growing demand for OTC vitamins & dietary tablet supplements, sales are forecasted to reach over $XXB by 2031 in Canada Vitamins & Supplement ~XX% of Canadian consumers believe what they eat impacts their physical health, with nearly two-thirds (XX%) agreeing it also affects their emotional wellbeing, approximately 19% of Canadians manage the minor ailments by themselves Selfcare 10 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  11. 1.4 Key aspects of Canada OTC market Private Labels ▪ Private label OTC sales in Canada was about XX% in 2019 ▪ Stores often sell private label products at lower price than manufacturing product leading increase of popularity of OTC drugs ▪ Market share of private label products are expanding in all therapeutic categories including smoking cessation, pain, cough and cold, and gastrointestinal remedies Rx-to-OTC Switches Online Sales ▪ Recent studies show, reductions in annual prescription drug expenditure due to, XX% of total revenue is generated through online sales of OTC drugs ▪ Growth drivers include consumer’s desire for convenience, multiple product options, and the ability to price compare ▪ Amazon launched Basic Line with partnership with Perrigo, the largest OTC private label manufacturer ▪ More than XX prescription drugs are converted into OTC products by FDA in past 30 years ▪ New strategies of Rx-to-OTC is being developed by pharma giants Key Aspect s Sample Key Aspects Sample 11 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  12. Canada OTC Pharmaceutical Market Analysis 2. Growth Drivers & Restraints

  13. 2. Market Growth Drivers and Restrains Rising demand for treatments of minor ailments 1 Increasing number of health-conscious consumers 2 Irrational use of medicines due to self-diagnosis / misdiagnosis 1 3 Product Innovation Drug abuse, possibilities of drug addiction 2 Switching of Rx Drugs to OTC 4 13 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  14. 2.1 Market Growth Drivers 2.1.1 Rising demand for treatments of minor ailments Ontario is in the process of establishing a plan for allowing pharmacists to prescribe for minor ailments. Eight provinces across Canada already allow pharmacist prescribing for minor ailments, and the style of billing varies province to province ▪ 1. 1 1. 2 Canadian estimates show that 10 to 30% of physician consultations are for minor ailments. This has led to increased non-prescription recommendations, facilitating self care ▪ Sample 1. 4 14 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  15. Market Growth Drivers (continued) 2.1.2 Increasing Number of Health-Conscious Consumers 2. 1 ▪ More than two-third of the Canadian population is making conscious efforts to improve their health 2. 2 According to research, more than half of Canadian consumers are proactively trying to lose weight to take charge of their health ▪ 2.3 Sample 2. 4 15 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  16. Market Growth Drivers (continued) 2.1.3 Product Innovation Several companies have been opting for several innovative marketing strategies, to capture a market share as high as possible ▪ Key industry players are involved in R&D to develop and market new OTC drugs for various health conditions ▪ Moreover, in 2020, the launch of Terpacan OTC drug for back and muscle pain and hemorrhoids in Canada after receiving approval of Health Canada by Tetra Bio-Pharma has also been driving the overall market growth ▪ Sample 16 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  17. Market Growth Drivers (continued) 2.1.4 Switching of Rx Drugs to OTC Several companies have been opting for several innovative marketing strategies, to capture a market share as high as possible ▪ Key industry players are involved in R&D to develop and market new OTC drugs for various health conditions. For instance, In 2019, Innovus Pharma launched Xyralid Suppositories in Canada, for the reduction of swelling or inflammation of hemorrhoidal tissues and provides pain relief from burning, itching and discomfort ▪ Sample 17 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  18. 2.2 Market Restraints 2.2.1 Irrational use of medicines due to self- diagnosis / misdiagnosis 2.2.2 Drug abuse, possibilities of drug addiction Consumption of wrong medication due to incorrect self-diagnosis or misdiagnosis may lead to severe complications and is one of the key factor that may hinder the market growth All OTC medication carries risk, primarily risk of tolerance and dependence by OTC painkillers ▪ ▪ High and more frequent doses of OTC drugs can lead to phycological dependence ▪ Many OTC cold and cough products have led to medication errors and cause adverse effects on the patient’s body ▪ Sample Sample 18 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  19. Canada OTC Pharmaceutical Market Analysis 3. Market Segmentation

  20. Canada Over the Counter (OTC) Market Segmentation By Drug Type Canada Over the Counter (OTC) Market Segmentation Market Restraints By Distribution Channel Type 20 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  21. Snapshot of OTC Market Segmentation By Drug Type By Distribution Channel Online Channels Offline Channels Analgesics Cold & Cough Remedies Vitamins & Minerals Digestive & Intestinal Remedies Skin Treatment Hand Sanitizer ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 21 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  22. 3.1 Market Segmentation: By Drug Type Canada Over the Counter (OTC) Market Share by Drug Type 2022 Key Summary The analgesics segment held the largest share of the market in 2021, whereas the hand sanitizer segment is anticipated to register the highest CAGR in the market during the forecast period ▪ Sample Growing number of head and back pain cases coupled with increasing number of new product launches in this segment contribute towards Analgesics market growth ▪ The use of vitamins, minerals, and other nutritional supplements has been increasing, due to their easy availability over the counter ▪ 2021 2022F 2023F 2024F 2025F Analgesics Cold & Cough Remedies Sample Vitamins & Minerals Skin Digestive & Intestinal Remedies Treatment Hand Sanitizer 22 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  23. 3.2 Market Segmentation: By Distribution Channel Canada Over the Counter (OTC) Market Share by Distribution Channel, 2022 Key Summary The hospital pharmacies are growing at a high rate, as Medical practices, hospitals, and their patients are increasingly obtaining over the counter drugs through hospital pharmacies ▪ Sample In today's scenario, the public is increasingly adopting retail pharmacy as a one-stop-shop to buy all the OTC products which drives the growth of offline pharmacies in Canada ▪ 2021 2022F 2023F 2024F 2025F Sample Offline Online 23 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  24. Canada OTC Pharmaceutical Market Analysis 4. Major Market Share

  25. 4.1 Major Canada Over the Counter (OTC) Products Market Share Key Insights Canada Over the Counter (OTC) Major Products Market Share 9 8 7 6 5 Top Brands in Canada Over the Counter (OTC) Therapeutic Market 4 3 2 1 0 0 1 2 3 4 5 Brand 1 Brand 2 Brand3 Brand 4 Sample 25 A Sample Report on Global Gram-Negative Infection Therapeutic Market I Confidential

  26. Canada OTC Pharmaceutical Market Analysis 5. Competitive Landscape

  27. 5.1 Competitive Landscape: Key Players Revenue (Current and Forecasted) Major Market Revenue of Physiotherapy Therapeutic Companies ($Bn) 2021 2022F 2023F 2024F 2025F $XX $XX $XX $XX $ 93.7 Johnson and Johnson Inc $XX $XX $XX $XX $ 81.3 Pfizer Inc. $XX $XX $XX $XX $XX Novartis $XX $XX $XX $XX $XX Bayer AG $XX $XX $XX $XX $XX GlaxoSmithKline plc Sample 27 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  28. Canada OTC Pharmaceutical Market Analysis 6. Key Company Profiles

  29. 6.1 Johnson and Johnson Inc Company Profile Company Name: Johnson and Johnson Inc Johnson & Johnson is the largest and most broadly based healthcare company in the world. It is specializes in the areas of health care, medical devices & diagnostics, pharmaceuticals and consumer packaged goods ▪ Year of Establishment: 1886 Headquarter: New Jersey, USA Revenue: $93.7B Website: https://www.jnj.com/ Sample 29 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  30. 6.2 Pfizer Inc Company Profile Company Name: Pfizer Inc Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and sells healthcare products, worldwide ▪ Year of Establishment: 1849 Headquarter: New York, United States Revenue: $81.3B Website: https://www.pfizer.com/ Sample 30 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  31. Pfizer Inc (Continued) Revenues ($Bn), 2021-2030F Breakdown of net revenue by segment, 2022 XX $XX Bn 2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 1 2 3 4 Analysis Sample 31 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  32. 6.3 Novartis Company Profile Company Name: Novartis Novartis AG is a global pharmaceutical company, by both market capitalization and sales. It has two business operating divisions: Innovative Medicines and Sandoz (generics) ▪ Year of Establishment: 1996 Headquarter: Basel, Switzerland Revenue: $51.6B Website: https://www.novartis.in/ Sample 32 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  33. Novartis (Continued) Revenues ($Bn), 2021-2030F Breakdown of net revenue by segment, 2022 XX $XX Bn 2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 1 2 3 4 Analysis Sample 33 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  34. 6.4 Bayer AG Company Profile Company Name: Bayer AG Bayer is a Life Science company with a more than 150- year history and core competencies in the areas of health care and agriculture The pharmaceutical division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology ▪ Year of Establishment: 1863 ▪ Headquarter: Leverkusen, Germany Revenue: $48.9B Website: https://www.bayer.com Sample 34 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  35. Bayer AG (Continued) Revenues ($Bn), 2021-2030F Breakdown of net revenue by segment, 2022 XX $XX Bn 2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 1 2 3 4 Analysis Sample 35 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  36. 6.5 Sanofi Company Profile Company Name: Sanofi Sanofi SA is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions ▪ Year of Establishment: 2004 Headquarter: Paris, France Revenue: $41.9B Website: https://www.sanofi.com/ Sample 36 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  37. Sanofi (Continued) Revenues ($Bn), 2021-2030F Breakdown of net revenue by segment, 2022 XX $XX Bn 2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 1 2 3 4 Analysis Sample 37 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  38. Canada OTC Pharmaceutical Market Analysis 7. Notable Deals

  39. Sanofi signed an agreement with Roche for the exclusive OTC rights to Tamiflu Sanofi Roche Sample Sample Sample 39 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  40. Canada OTC Pharmaceutical Market Analysis 8. Healthcare Policy and Regulatory Landscape

  41. 8.1 Regulatory Framework of Canada OTC Market Health Canada is the federal authority responsible for regulating pharmaceutical drugs, biologicals, and medical devices for human use The Food and Drug Regulations, Natural Health Products Regulations, and Medical Devices Regulations make up the general regulatory framework Non-prescription drugs require a valid Drug Identification Number (DIN) to be sold in Canada. On a product label, this number indicates the drug has met the requirements for safety, quality and effectiveness Sample Sample 41 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  42. Canada OTC Pharmaceutical Market Analysis 9. Future Opportunities

  43. 9.1 Key developments in Canada OTC market Harness the spirit of experimentation to maximize RWE potential for OTC Dell Tech Real world evidence (RWE) has been a driving force in prescription drug development and commercial decision making for years, but it has yet to take hold in the over the counter (OTC) medicines landscape The Canadian over-the-counter product registration process is time-consuming and complex. Registrants must have labels reviewed against the various monographs and formulations reviewed against the Natural Health Products Ingredients Database (NHPID) ▪ ▪ 43 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  44. Canada OTC Pharmaceutical Market Analysis 10. Strategic Recommendations

  45. 10. Wayforward Availability Major OTC drugs were sold to retail drug stores and hospitals from where the consumer can buy easily Government funding and Reimbursement Territorial governments are responsible for the administration of their own publicly funded prescription benefit programs Affordability As there is a lack of awareness among people for blood donations, government and hospitals are rolling out schemes to attract donors like paid donations 3 2 4 Future Opportunities Understanding the epidemiologic aspects of any public health problem in terms of its dynamic (prevalence), distribution, and determinants is critical for prevention and control Increasing Demand Growing demand for OTC drugs . Every year the demand will increase in upcoming years 5 1 45 A Sample Report on Canada Over the Counter (OTC) Market I Confidential

  46. Methodology & Scope

  47. Research Methodology Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources For forecasting, the following parameters are considered: ❑ Market drivers and restraints along with their current and expected impacts ❑ Technological scenario and expected developments ❑ End use industry trends and dynamics ❑ Trends in the consumer behavior ❑ Regulatory scenario and expected developments ❑ Current capacity and expected capacity additions up to 2030 We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time- sensitive, reflecting the most recent value and volume of the market across regions All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs) Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) ▪ ▪ ▪ ▪ ▪ ▪ ▪ 47 A Sample Report on Canada Over The Counter (OTC) Market I Confidential

  48. Analysis Methodology Our Analysis Methodology involves three critical stages: Market Data Analysis & Statistical Model Interpretation & Presentation Data Collection Analysis & Interpretation Market Trends Secondary Research Market Sizing & Analysis Insights Primary Research Presentation & Reporting Data Triangulation & Validation 48 A Sample Report on Canada Over The Counter (OTC) Market I Confidential

  49. Data Triangulation & Data Validation Top Down Approach Final Market Size Final Market size break up to rest of segmentation Validation from Primary Interview Arriving at market size of each segment Summarization of revenue generated from companies to arrive at total market size Validation from Primary Interview Revenue generated by products & services offered by companies Final Summary Bottom Up Approach 49 A Sample Report on Canada Over The Counter (OTC) Market I Confidential

  50. Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 50 A Sample Report on Canada Over The Counter (OTC) Market I Confidential

More Related